FitLife Brands, Inc. (FTLF) Market Cap
FitLife Brands, Inc. has a market capitalization of $88M.
Financials based on reported quarter end 2025-12-31
Price: $9.38
▲ 0.39 (4.28%)
Market Cap: 88.04M
NASDAQ · time unavailable
CEO: Dayton Robert Judd
Sector: Consumer Defensive
Industry: Packaged Foods
IPO Date: 2007-11-02
Website: https://www.fitlifebrands.com
FitLife Brands, Inc. (FTLF) - Company Information
Market Cap: 88.04M · Sector: Consumer Defensive
FitLife Brands, Inc. provides nutritional supplements for health-conscious consumers in the United States and internationally. It offers weight loss, general health, and sports nutrition supplements; precision sports nutrition formulations for professional muscular development; weight loss and sports nutrition performance enhancing supplements for fitness enthusiasts; and men's health and weight loss formulations, as well as other diet, health, and sports nutrition supplements and related products; and sports nutritional products, energy and weight loss products, and meal replacements. It markets its products under the brand names of NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize through franchised stores, as well as through various retail locations, including specialty, mass, and online. The company was formerly known as Bond Laboratories, Inc. and changed its name to FitLife Brands, Inc. in September 2013. FitLife Brands, Inc. was incorporated in 2005 and is headquartered in Omaha, Nebraska.
Analyst Sentiment
Based on 2 ratings
Analyst 1Y Forecast: $0.00
Average target (based on 1 sources)
Consensus Price Target
Low
$21
Median
$31
High
$40
Average
$31
Potential Upside: 225.3%
Price & Moving Averages
Related Companies in Consumer Defensive
SOLESENCE INC (SLSN)
Consumer Defensive
$0.09B
Mkt Cap
ZEVIA CLASS A (ZVIA)
Consumer Defensive
$0.09B
Mkt Cap
ISPIRE TECHNOLOGY INC (ISPR)
Consumer Defensive
$0.10B
Mkt Cap
HAIN CELESTIAL GROUP INC (HAIN)
Consumer Defensive
$0.07B
Mkt Cap
SKILLSOFT CORP CLASS A (SKIL)
Consumer Defensive
$0.07B
Mkt Cap
LIFEVANTAGE CORP (LFVN)
Consumer Defensive
$0.07B
Mkt Cap
Fundamentals Overview
📊 AI Financial Analysis
Powered by StockMarketInfo"Frontier Technology Ltd. (FTLF) reported revenue of $25.9M and net income of $1.64M for the latest period (EPS: $0.17), implying a net margin of ~6.3%. Free cash flow was ~$3.9M (FCF margin ~15.1%) with operating cash flow of ~$3.9M and minimal capital expenditure ($0.013M), indicating strong cash conversion for the period. On the balance sheet, total assets were ~$106.3M versus total liabilities of ~$62.7M, leaving equity of ~$43.6M. Net debt was ~$10.8M, or about 0.25x equity, suggesting moderate leverage and room to absorb earnings volatility. Shareholder returns look mixed. Price performance has been weak recently (6-month: -38.6%; YTD: -23.2%), while the 1-year gain is modest (+2.1%). There were no dividends paid in the latest cash flow data, and no buyback information was provided, so total return appears driven primarily by share price. Valuation context is incomplete because key multiples (e.g., P/E, FCF yield, ROE, market cap) were not provided. Analyst targets show a wide range ($21–$40, consensus ~$30.5), reflecting uncertainty around future fundamentals. Overall, profitability and cash generation are positives, but near-term market performance and limited shareholder-return components weigh on the score."
Revenue Growth
Only one-quarter snapshot is provided (revenue $25.9M) with no YoY or sequential growth rate, limiting assessment of momentum or stability.
Profitability
Net income of $1.64M on $25.9M revenue implies ~6.3% net margin. EPS of $0.17 suggests positive earnings generation, though margin level appears moderate.
Cash Flow Quality
Operating cash flow was ~$3.9M and free cash flow was ~$3.9M, with minimal capex (~$0.013M). This points to strong cash conversion for the period. Dividends paid were $0 in the latest cash flow data.
Leverage & Balance Sheet
Net debt of ~$10.8M versus equity of ~$43.6M (~0.25x) indicates manageable leverage. Liquidity resilience appears reasonable based on provided net debt and equity figures.
Shareholder Returns
Recent market performance has been negative (6-month -38.6%, YTD -23.2%) and dividends are not paid in the latest period. Without buyback data, total shareholder return appears mainly tied to share price, which has weakened.
Analyst Sentiment & Valuation
Market multiples were not provided, but analyst targets imply uncertainty (consensus ~$30.5 vs. $21–$40 range). With the stock at $12.1, upside is heavily dependent on improving outlook.
Disclaimer:This analysis is AI-generated for informational purposes only. Accuracy is not guaranteed and this does not constitute financial advice.
FitLife’s Q4 2025 results show sharp top-line gains from the Irwin acquisition (+73% revenue; +213% wholesale) but margin dilution from Irwin’s historically lower gross margin (37.0% vs 41.4%) and acquisition-related inventory step-up amortization. Legacy FitLife was meaningfully weaker (-12% total revenue YoY) with contribution margin down 240 bps to 32.5%, driven by MRC and MusclePharm, while other legacy brands grew 4%. The core turnaround case is operational: Irwin has had ~$2M/year of obsolete inventory write-offs due to 2-year dating and MOQs; management targets +300–400 bps Irwin gross margin expansion once products transition to 3-year shelf life, with expected P&L flow beginning in Q2 2026. Demand-side progress is strongest online—Irwin Amazon monthly revenue rose from ~$0.5M (Dec) to ~$0.8M (early Q1), implying ~$9–10M annual run-rate. Management provided no 2026 guidance, citing Q1 tracking similar to Q4 and uncertainty whether Irwin’s online growth can offset macro and Amazon-related pressures.
Growth Catalysts
- Irwin supply chain improvements targeting obsolete inventory reduction (transition toward 3-year shelf life) to reduce charge-offs and lift margins
- Irwin online (Amazon) ramp: monthly revenue rose to ~$0.5M by Dec 2025 and ~$0.8M by early Q1 2026; noted ~9–10M annualized run-rate with higher margins than wholesale
- New Irwin product launches: 3 products in production expected to launch in Q3 2026
- Off-Amazon demand generation to support Amazon performance (TikTok engagement increasing; Dr. Tobias brand marketing push)
- Wholesale cross-sell using Irwin sales team: placement gained for 6 MusclePharm SKUs in a regional grocery chain starting Q2 2026
Business Development
- Dr. Tobias partnership finalized with Joey Chestnut (Hero Colon Cleanse) to drive demand
- 6 MusclePharm SKUs placed in a regional grocery chain (beginning Q2 2026)
- Irwin scaled on Amazon after starting sales mid-October 2025 (Amazon account cited as fastest-growing)
Financial Highlights
- Total revenue: $25.9M (+73% YoY) largely from Irwin acquisition; legacy FitLife weakness partially offset
- Wholesale revenue: $15.5M (60% of revenue), +213% YoY
- Online revenue: $10.5M (40% of revenue), +4% YoY
- Gross margin: 37.0% vs 41.4% in Q4 2024; decline primarily due to Irwin acquisition (Irwin historically lower margin)
- Contribution: +47% to $ (implied) $4.3M for legacy FitLife; company-wide driven by Irwin addition offset by lower legacy contribution
- Net income: $1.6M vs $2.1M prior year; decline driven by transaction-related expense and inventory step-up amortization
- Adjusted EBITDA: $3.5M (+14% YoY)
- Legacy FitLife Q4 2025 revenue: $13.3M; -12% YoY total (-10% online, -14% wholesale); wholesale -14% and online -10% YoY
- Legacy FitLife contribution margin: 32.5% vs 34.9% (down 240 bps)
- Irwin Q4 2025 gross margin: 28.0%; contribution margin: 26.6%
- Irwin adjusted for inventory step-up amortization: gross margin would have been 33.2% and contribution margin 31.8%
- Irwin obsolete inventory: historically ~$2M/year written off (expensed in COGS) tied to high MOQs and 2-year dating vs wholesale 12-month shelf-life requirements
Capital Funding
- Debt reduction: paid down ~$1.9M term loan in Q4 2025; debt balance reduced to $44.7M
- Revolver: reduced by ~$1.4M during Q1 2026
- Additional scheduled term-loan amortization payment: ~$1.5M made 'yesterday' (as of call date)
- No explicit buyback amount disclosed in provided transcript; guidance on using excess free cash flow to reduce indebtedness
Strategy & Ops
- Irwin supply chain: hiring new VP of Operations for Irwin in February; confidence of meaningful supply chain improvement throughout 2026
- Shelf life change plan: transition slower-moving Irwin products from 2-year to 3-year shelf life to extend selling window (12 months -> 24 months) and reduce obsolete inventory
- Timing: first products with 3-year dating received; expecting P&L impact in Q2 and onward
- Inventory obsolescence target impact: reducing obsolescence could increase Irwin gross margin by as much as +300 to +400 bps with dollar-for-dollar EBITDA impact
- Irwin stockouts: impact pronounced in Q1; ongoing improvement tied to supply chain execution
- Amazon algorithm shift view: describes A9 -> 'A10' prioritizing external traffic/organic engagement; brands more dependent on Amazon struggle (Dr. Tobias worst; Irwin best)
- SG&A efficiency: office lease exit for MRC (Toronto) completed at lease expiration January (employees already working from home)
- SG&A/lease cost reset: Irwin office lease expires later in 2026; anticipates smaller space and substantially lower cost per square foot due to LA office market softness
Market Outlook
- No formal full-year 2026 guidance due to weakness in Q1 and uncertainty on duration of exogenous challenges and internal execution timing
- Q1 tracking: “Q1 looks a whole lot like Q4” and “Q1 looks…like Q4” (sequential expectation: Q1 flat to down from Q4)
- Company holds off on guidance numbers; expects Irwin online growth may or may not fully offset weakness elsewhere
Risks & Headwinds
- Broad-based consumer confidence weakness: consumer sentiment near all-time lows; discretionary spending declining since late last year and lowest level in past 4 years
- Legacy FitLife softness concentrated in MRC and MusclePharm (other legacy brands delivered organic growth of 4% in Q4)
- Amazon traffic/algorithmic headwinds: described as impact from Amazon algorithm changes prioritizing external traffic; brands with greater Amazon dependence struggle
- Irwin operational headwinds: obsolete inventory write-offs (~$2M/year) and stock-outs; both linked to 2-year dating and supply chain variability
- Irwin customer/product normalization already undertaken: Costco U.S. discontinued Irwin products early 2025; Rite Aid bankruptcy/liquidation prior to acquisition; CBD discontinued post-acquisition due to legal complexity
Sentiment: MIXED
Note: This summary was synthesized by AI from the FTLF Q4 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.